Open AccessLong-term treatment with the dopamine agonist quinagolide of patients with clinically non-functioning pituitary adenoma
Author(s) -
FR Nobels,
WW de Herder,
WM van den Brink,
DJ Kwekkeboom,
Leo J. Hofland,
Joke Zuyderwijk,
FH de Jong,
SW Lamberts
Publication year - 2000
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje.0.1430615
Subject(s) - medicine , dopamine , dopamine agonist , agonist , endocrinology , magnetic resonance imaging , urology , receptor , radiology
This study was performed to evaluate the effect of prolonged treatment with the dopamine agonist quinagolide on serum gonadotropin and alpha-subunit concentrations and tumor volume in patients with clinically non-functioning pituitary adenomas (CNPA).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom